Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Hypertension? 660 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 660 reports of Hypertension have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 17.6% of all adverse event reports for BOTULINUM TOXIN TYPE A.

660
Reports of Hypertension with BOTULINUM TOXIN TYPE A
17.6%
of all BOTULINUM TOXIN TYPE A reports
543
Deaths
461
Hospitalizations

How Dangerous Is Hypertension From BOTULINUM TOXIN TYPE A?

Of the 660 reports, 543 (82.3%) resulted in death, 461 (69.8%) required hospitalization, and 465 (70.5%) were considered life-threatening.

Is Hypertension Listed in the Official Label?

Yes, Hypertension is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Hypoaesthesia (703) Nausea (665)

What Other Drugs Cause Hypertension?

ADALIMUMAB (9,032) METHOTREXATE (7,143) RITUXIMAB (6,760) PREDNISONE (6,087) INFLIXIMAB (5,874) ETANERCEPT (5,677) TOCILIZUMAB (5,492) ABATACEPT (5,114) TOFACITINIB (4,991) ALENDRONATE (4,373)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Hypertension Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Hypertension Reports All Drugs Causing Hypertension BOTULINUM TOXIN TYPE A Demographics